Compare Panacea Biotech with - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

PANACEA BIOTECH vs ALKEM LABORATORIES - Comparison Results

PANACEA BIOTECH     Change

Panacea Biotec is the second largest vaccine producer in India and has been ranked as the third largest biotechnology company in India (as per ABLE Survey 2006). While vaccines account for two-thirds of the company's overall revenues, the balance com... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    PANACEA BIOTECH ALKEM LABORATORIES PANACEA BIOTECH/
ALKEM LABORATORIES
 
P/E (TTM) x 15.1 23.0 65.5% View Chart
P/BV x 5.9 5.6 105.8% View Chart
Dividend Yield % 0.0 0.9 -  

Financials

 PANACEA BIOTECH   ALKEM LABORATORIES
EQUITY SHARE DATA
    PANACEA BIOTECH
Mar-19
ALKEM LABORATORIES
Mar-20
PANACEA BIOTECH/
ALKEM LABORATORIES
5-Yr Chart
Click to enlarge
High Rs3542,720 13.0%   
Low Rs1381,660 8.3%   
Sales per share (Unadj.) Rs74.6697.9 10.7%  
Earnings per share (Unadj.) Rs6.796.1 6.9%  
Cash flow per share (Unadj.) Rs15.5117.3 13.2%  
Dividends per share (Unadj.) Rs025.00 0.0%  
Dividend yield (eoy) %01.1 0.0%  
Book value per share (Unadj.) Rs57.2515.2 11.1%  
Shares outstanding (eoy) m61.25119.57 51.2%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x3.33.1 105.1%   
Avg P/E ratio x36.822.8 161.6%  
P/CF ratio (eoy) x15.918.7 85.0%  
Price / Book Value ratio x4.34.3 101.1%  
Dividend payout %026.0 0.0%   
Avg Mkt Cap Rs m15,061261,879 5.8%   
No. of employees `0002.314.3 16.1%   
Total wages/salary Rs m1,47115,055 9.8%   
Avg. sales/employee Rs Th1,973.65,822.6 33.9%   
Avg. wages/employee Rs Th635.61,050.5 60.5%   
Avg. net profit/employee Rs Th176.8802.0 22.0%   
INCOME DATA
Net Sales Rs m4,56783,444 5.5%  
Other income Rs m451,042 4.3%   
Total revenues Rs m4,61284,486 5.5%   
Gross profit Rs m2,03014,734 13.8%  
Depreciation Rs m5402,528 21.4%   
Interest Rs m1,048651 161.1%   
Profit before tax Rs m48612,598 3.9%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m771,105 7.0%   
Profit after tax Rs m40911,493 3.6%  
Gross profit margin %44.417.7 251.7%  
Effective tax rate %15.98.8 180.8%   
Net profit margin %9.013.8 65.0%  
BALANCE SHEET DATA
Current assets Rs m2,41554,960 4.4%   
Current liabilities Rs m9,07732,433 28.0%   
Net working cap to sales %-145.927.0 -540.4%  
Current ratio x0.31.7 15.7%  
Inventory Days Days6580 81.8%  
Debtors Days Days7172 98.3%  
Net fixed assets Rs m8,33332,710 25.5%   
Share capital Rs m61239 25.6%   
"Free" reserves Rs m3,44361,368 5.6%   
Net worth Rs m3,50461,607 5.7%   
Long term debt Rs m4611,592 29.0%   
Total assets Rs m13,75599,433 13.8%  
Interest coverage x1.520.4 7.2%   
Debt to equity ratio x0.10 509.2%  
Sales to assets ratio x0.30.8 39.6%   
Return on assets %10.612.2 86.8%  
Return on equity %11.718.7 62.6%  
Return on capital %38.721.0 184.6%  
Exports to sales %20.919.1 109.5%   
Imports to sales %8.13.0 273.7%   
Exports (fob) Rs m95415,917 6.0%   
Imports (cif) Rs m3722,483 15.0%   
Fx inflow Rs m1,20316,061 7.5%   
Fx outflow Rs m4672,483 18.8%   
Net fx Rs m73613,578 5.4%   
CASH FLOW
From Operations Rs m1,0495,851 17.9%  
From Investments Rs m-54-7,414 0.7%  
From Financial Activity Rs m-1,011792 -127.8%  
Net Cashflow Rs m-20-731 2.7%  

Share Holding

Indian Promoters % 74.5 66.9 111.4%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 0.6 33.1 1.8%  
FIIs % 1.3 0.0 -  
ADR/GDR % 0.0 0.0 -  
Free float % 23.6 0.0 -  
Shareholders   10,259 68,381 15.0%  
Pledged promoter(s) holding % 35.1 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare PANACEA BIOTECH With:   STRIDES PHARMA SCIENCE  AJANTA PHARMA  UNICHEM LAB  NATCO PHARMA  CADILA HEALTHCARE  

Compare PANACEA BIOTECH With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Ends 272 Points Higher; Hindalco, Hero MotoCorp & Wipro Surge Over 4%(Closing)

Indian share markets witnessed volatile trading activity throughout the day today and ended higher.

Related Views on News

Most Popular

Power Grid's InvIT IPO: Key Points to Consider(Company Info)

Apr 23, 2021

In this article, we discuss the key reasons why the stock of Power Grid was in focus today.

Time to Buy Smallcaps?(Fast Profits Daily)

Apr 30, 2021

In this video, I'll show you why I favour smallcaps over the Nifty.

The Next Smallcap Winners(Profit Hunter)

Apr 30, 2021

Price is the only due diligence one might require to buy this business.

This Fund Manager Has Taken the World by Storm. Will You Invest With Her?(Profit Hunter)

Apr 26, 2021

Should you invest with this Rockstar fund manager who has outperformed in a big way?

More

India's #1 Trader
Reveals His Secrets

Secret To Increasing Your Trading Profits Today
Get this Special Report,
The Secret to Increasing Your Trading Profits Today, Now!
We will never sell or rent your email id.
Please read our Terms

PANACEA BIOTECH SHARE PRICE


May 6, 2021 (Close)

TRACK PANACEA BIOTECH

  • Track your investment in PANACEA BIOTECH with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON PANACEA BIOTECH

PANACEA BIOTECH 5-YR ANALYSIS

COMPARE PANACEA BIOTECH WITH

MARKET STATS